Contemporary analysis of ETEST for antibiotic susceptibility and minimum inhibitory concentration agreement against Pseudomonas aeruginosa from patients with cystic fibrosis

被引：0
|
作者：
Maxwell J. Lasko
Holly K. Huse
David P. Nicolau
Joseph L. Kuti
机构：
[1] Hartford Hospital,Center for Anti
[2] Huntington Hospital,Infective Research and Development
[3] Hartford Hospital,Department of Clinical Microbiology
[4] Harbor-UCLA Medical Center,Division of Infectious Diseases
来源：
Annals of Clinical Microbiology and Antimicrobials | / 20卷
关键词：
Antibiotic resistance; Broth microdilution; Ceftazidime–avibactam; Ceftolozane–tazobactam;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [21] Mechanisms of intrinsic resistance and acquired susceptibility of Pseudomonas aeruginosa isolated from cystic fibrosis patients to temocillin, a revived antibiotic
    Hussein Chalhoub
    Daniel Pletzer
    Helge Weingart
    Yvonne Braun
    Michael M. Tunney
    J. Stuart Elborn
    Hector Rodriguez-Villalobos
    Patrick Plésiat
    Barbara C. Kahl
    Olivier Denis
    Mathias Winterhalter
    Paul M. Tulkens
    Françoise Van Bambeke
    Scientific Reports, 7
  • [22] Mechanisms of intrinsic resistance and acquired susceptibility of Pseudomonas aeruginosa isolated from cystic fibrosis patients to temocillin, a revived antibiotic
    Chalhoub, Hussein
    Pletzer, Daniel
    Weingart, Helge
    Braun, Yvonne
    Tunney, Michael M.
    Elborn, J. Stuart
    Rodriguez-Villalobos, Hector
    Plesiat, Patrick
    Kahl, Barbara C.
    Denis, Olivier
    Winterhalter, Mathias
    Tulkens, Paul M.
    Van Bambeke, Francoise
    SCIENTIFIC REPORTS, 2017, 7
  • [23] INVESTIGATION OF BIOFILM FORMATION AND RELATIONSHIP WITH GENOTYPE AND ANTIBIOTIC SUSCEPTIBILITY OF PSEUDOMONAS AERUGINOSA STRAINS ISOLATED FROM PATIENTS WITH CYSTIC FIBROSIS
    Coban, Ahmet Yilmaz
    Ciftci, Alper
    Onuk, Ertan Emek
    Erturan, Zayre
    Cayci, Yeliz Tanriverdi
    Durupinar, Belma
    MIKROBIYOLOJI BULTENI, 2009, 43 (04): : 563 - 573
  • [24] Changes in Antibiotic Sensitivities in Cystic Fibrosis Patients with Pseudomonas Aeruginosa Colonisation
    See, W.
    McCarthy, C.
    Dunican, E. M.
    Cullinan, N. M.
    O'Donohoe, C.
    Bolton, C.
    Gunaratnam, C. M.
    McElvaney, N. G.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2009, 179
  • [25] Influence of biofilm formation in the susceptibility of Pseudomonas aeruginosa from Brazilian patients with cystic fibrosis
    Ferreira, Alex Guerra
    Leao, Robson Souza
    D'Alincourt Carvalho-Assef, Ana Paula
    Folescu, Tania Wrobel
    Barth, Afonso Luis
    Marques, Elizabeth Andrade
    APMIS, 2010, 118 (08) : 606 - 612
  • [26] Antimicrobial Susceptibility of Pseudomonas aeruginosa Isolated from Cystic Fibrosis Patients in Northern Europe
    Mustafa, Muhammad-Hariri
    Chalhoub, Hussein
    Denis, Olivier
    Deplano, Ariane
    Vergison, Anne
    Rodriguez-Villalobos, Hector
    Tunney, Michael M.
    Elborn, J. Stuart
    Kahl, Barbara C.
    Traore, Hamidou
    Vanderbist, Francis
    Tulkens, Paul M.
    Van Bambeke, Francoise
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2016, 60 (11) : 6735 - 6741
  • [27] Heterogeneous Antimicrobial Susceptibility Characteristics in Pseudomonas aeruginosa Isolates from Cystic Fibrosis Patients
    Qin, Xuan
    Zhou, Chuan
    Zerr, Danielle M.
    Adler, Amanda
    Addetia, Amin
    Yuan, Shuhua
    Greninger, Alexander L.
    MSPHERE, 2018, 3 (02)
  • [28] Susceptibility of Pseudomonas aeruginosa to cefepime versus ceftazidime in patients with cystic fibrosis
    Robinson, CA
    Kuhn, RJ
    Craigmyle, LJ
    Anstead, MI
    Kanga, JF
    PHARMACOTHERAPY, 2001, 21 (11): : 1320 - 1324
  • [29] In vitro activity of cefiderocol against Pseudomonas aeruginosa isolated from cystic fibrosis patients
    Monogue, Marguerite L.
    Desai, Dhara
    Pybus, Christine A.
    Sanders, James M.
    Clark, Andrew E.
    Greenberg, David E.
    MICROBIOLOGY SPECTRUM, 2023, 11 (06):
  • [30] In vitro pharmacodynamics of ceftazidime against Pseudomonas aeruginosa isolates from cystic fibrosis patients
    Manduru, M
    Mihm, LB
    White, RL
    Friedrich, LV
    Flume, PA
    Bosso, JA
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1997, 41 (09) : 2053 - 2056
12345